Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127649261 | 12764926 | 1 | I | 20160831 | 20160913 | 20160921 | 20160921 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075945 | BRISTOL MYERS SQUIBB | 56.97 | YR | F | Y | 0.00000 | 20160921 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127649261 | 12764926 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 140 MG, QD | U | 21986 | 140 | MG | FILM-COATED TABLET | QD | |||||
127649261 | 12764926 | 2 | C | BACLOFEN. | BACLOFEN | 1 | Unknown | UNK | U | 0 | |||||||||
127649261 | 12764926 | 3 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127649261 | 12764926 | 1 | Chronic myeloid leukaemia |
127649261 | 12764926 | 2 | Product used for unknown indication |
127649261 | 12764926 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127649261 | 12764926 | HO |
127649261 | 12764926 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127649261 | 12764926 | Hospitalisation |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127649261 | 12764926 | 1 | 20130201 | 0 |